Profile data is unavailable for this security.
About the company
ADDvise Group AB, formerly ADDvise Lab Solutions publ AB, is a Sweden-based company principally engaged in the supply of fittings, equipment and safety ventilation for laboratory environments. The Company’s service range also includes the delivery, installation, furnishing and validation of clean rooms. The Company’s operations are divided into two business areas, namely ADDvise KEBO and ADDvise Tillquist. The ADDvise KEBO area focuses on the furnishings and protective ventilation. The ADDvise Tillquist area focuses on laboratory equipment, supplies and wave technologies. Additionally, it operates under such brand names, as ADDvise, KEBO Inredningar and Tillquist. As of December 31, 2011, it had three wholly owned subsidiaries, such as KEBO Inredningar Sverige AB, ADDvise Tillquist AB and addVise internordic AB, as well as held 50% shares of advise Ltd.
- Revenue in SEK (TTM)1.48bn
- Net income in SEK110.80m
- Incorporated1989
- Employees620.00
- LocationADDvise Group AB (publ)Grev Turegatan 30STOCKHOLM 114 38SwedenSWE
- Phone+46 812876600
- Websitehttps://www.addvisegroup.se/
More ▼
Mergers & acquisitions
| Acquired company | ADDV A:STO since announced | Transaction value |
|---|---|---|
| Labplan Ltd | 14.34% | -- |
| Axelerist Inc | 13.50% | 29.40m |
Data delayed at least 15 minutes, as of Jul 23 2024 17:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioretec Oy | 45.66m | -44.28m | 682.10m | 37.00 | -- | 6.81 | -- | 14.94 | -0.1984 | -0.1984 | 0.2047 | 0.4213 | 0.5524 | 1.46 | 3.68 | 105,594.60 | -53.58 | -67.11 | -65.75 | -97.60 | 69.85 | 70.97 | -96.98 | -134.05 | 4.86 | -4.02 | 0.0754 | -- | 32.77 | 19.77 | -56.82 | -- | -- | -- |
| SyntheticMR AB (publ) | 90.86m | 15.67m | 683.69m | 38.00 | 43.11 | 5.69 | 30.94 | 7.53 | 0.3804 | 0.3804 | 2.21 | 2.88 | 0.6719 | -- | 1.58 | 2,455,541.00 | 11.59 | 7.19 | 13.87 | 8.85 | 73.94 | 69.70 | 17.25 | 9.08 | -- | -- | 0.0083 | 21.50 | 30.67 | 13.05 | 70.34 | -7.33 | 27.30 | -- |
| Omda AS | 407.73m | 86.39m | 762.67m | 291.00 | 8.73 | 8.92 | 4.92 | 1.87 | 4.27 | 4.27 | 20.44 | 4.18 | 0.5534 | 168.94 | 10.73 | 1,432,536.00 | 12.70 | -4.92 | 16.78 | -6.37 | 92.56 | 90.22 | 22.96 | -9.83 | 1.25 | 2.58 | 0.8487 | -- | 12.30 | 19.83 | 179.30 | -- | -3.93 | -- |
| Mentice AB | 254.07m | -25.98m | 767.07m | 128.00 | -- | 5.66 | 1,870.89 | 3.02 | -1.01 | -1.01 | 10.03 | 5.30 | 0.8435 | 1.97 | 3.88 | 2,082,557.00 | -8.62 | -7.69 | -17.02 | -13.07 | 87.57 | 83.67 | -10.22 | -10.00 | 0.8586 | -- | 0.0553 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| Senzime AB (publ) | 40.59m | -131.28m | 771.35m | 52.00 | -- | 2.60 | -- | 19.01 | -1.30 | -1.30 | 0.3902 | 2.95 | 0.1045 | 1.34 | 5.80 | -- | -33.80 | -35.69 | -35.58 | -38.00 | 26.75 | -20.59 | -323.45 | -558.68 | 5.85 | -- | 0.0308 | -- | 154.77 | 61.90 | -1.09 | -- | -3.69 | -- |
| Gentian Diagnostics ASA | 139.10m | -5.71m | 844.72m | 58.00 | -- | 5.70 | 241.24 | 6.07 | -0.3783 | -0.3783 | 9.22 | 9.82 | 0.7646 | 1.85 | 6.35 | 2,452,035.00 | -3.14 | -10.76 | -3.58 | -11.86 | 50.84 | 41.46 | -4.10 | -26.99 | 4.14 | -- | 0.0555 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
| OssDsign AB | 117.72m | -118.39m | 881.86m | 48.00 | -- | 3.93 | -- | 7.49 | -1.51 | -1.51 | 1.40 | 2.30 | 0.3907 | 3.60 | 6.62 | 2,452,500.00 | -39.29 | -37.92 | -43.39 | -43.56 | 77.15 | 68.10 | -100.57 | -203.06 | 5.18 | -36.90 | 0.013 | -- | 96.84 | 53.26 | -31.30 | -- | -56.16 | -- |
| Integrum AB | 104.12m | 4.17m | 956.60m | 36.00 | 231.98 | 6.27 | 150.91 | 9.19 | 0.2199 | 0.2199 | 5.55 | 8.13 | 0.6307 | 0.5919 | 3.80 | 2,892,222.00 | 2.53 | 0.7612 | 2.80 | 0.8818 | 87.65 | 83.87 | 4.01 | 1.28 | 3.32 | -- | 0.043 | -- | 40.19 | 35.91 | 212.14 | -- | 127.10 | -- |
| Nightingale Health Oyj | 42.70m | -211.04m | 968.61m | 81.00 | -- | 1.38 | -- | 22.68 | -0.2979 | -0.2979 | 0.0603 | 1.50 | 0.0344 | 1.60 | 3.87 | 44,560.98 | -17.02 | -14.20 | -18.12 | -15.69 | 75.81 | 83.57 | -494.25 | -408.50 | 14.15 | -- | 0.0378 | -- | 80.80 | 19.05 | -12.38 | -- | -- | -- |
| Paxman AB (publ) | 226.42m | 23.97m | 1.06bn | 94.00 | 44.34 | 7.80 | 24.92 | 4.69 | 1.26 | 1.26 | 11.89 | 7.16 | 1.28 | 2.66 | 6.46 | 2,488,099.00 | 13.59 | -5.08 | 18.38 | -7.76 | 69.47 | 69.38 | 10.59 | -5.07 | 1.76 | -- | 0.1122 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
| ADDvise Group AB (publ) | 1.48bn | 110.80m | 1.20bn | 620.00 | 26.52 | 3.71 | 5.34 | 0.811 | 0.5864 | 0.5864 | 7.84 | 4.20 | 0.5506 | 6.73 | 5.52 | 2,365,224.00 | 4.14 | 3.72 | 5.17 | 4.77 | 47.63 | 48.95 | 7.51 | 5.89 | 1.09 | 2.99 | 0.6608 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
| Optomed Oyj | 174.70m | -51.10m | 1.36bn | 114.00 | -- | 5.48 | -- | 7.79 | -0.2575 | -0.2575 | 0.8872 | 1.08 | 0.5199 | 1.70 | 3.94 | 131,131.60 | -15.21 | -12.95 | -18.59 | -15.90 | 66.76 | 65.69 | -29.25 | -27.84 | 1.72 | -12.96 | 0.1894 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
| Nordhealth As | 428.93m | -129.67m | 1.46bn | 395.00 | -- | 2.64 | -- | 3.40 | -1.68 | -1.68 | 5.55 | 12.47 | 0.3561 | -- | 8.25 | 1,110,235.00 | -10.76 | -- | -12.25 | -- | 85.96 | -- | -30.23 | -- | -- | -- | 0.00 | -- | 18.60 | -- | 21.96 | -- | -- | -- |
| BioPorto A/S | 50.71m | -84.30m | 1.49bn | 27.00 | -- | 20.12 | -- | 29.33 | -0.1501 | -0.1501 | 0.0903 | 0.1099 | 0.4132 | 3.66 | 7.33 | 1,044,452.00 | -68.68 | -71.10 | -100.20 | -96.55 | 68.08 | 63.38 | -166.23 | -239.22 | 2.36 | -- | 0.1354 | -- | 6.87 | 3.54 | 25.81 | -- | -51.56 | -- |
| C Rad AB | 458.22m | 48.23m | 1.50bn | 89.00 | 31.99 | 5.30 | 26.16 | 3.28 | 1.43 | 1.43 | 13.57 | 8.61 | 1.20 | 4.90 | 3.05 | 5,266,839.00 | 12.69 | 5.09 | 17.96 | 7.02 | 45.14 | 43.12 | 10.61 | 4.86 | 2.43 | -- | 0.0058 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
Data as of Jul 23 2024. Currency figures normalised to ADDvise Group AB (publ)'s reporting currency: Swedish Krona SEK
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Russell Investments Ltd.as of 30 Sep 2023 | 0.00 | 0.00% |
| Acadian Asset Management LLCas of 30 Sep 2023 | 0.00 | 0.00% |
Data from 31 Mar 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
